SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950112-96-001127
Filing Date
1996-04-12
Accepted
1996-04-12 00:00:00
Documents
1
Group Members
ALBERTO W. VILARAMERINDO INVESTMENT ADVISORS (U.K.), LIMITEDAMERINDO INVESTMENT ADVISORS INCAMERINDO INVESTMENT ADVISORS, INC., PANAMA CORP.GARY A. TANAKA
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 HOUGHTON PHARMACEUTICALS, INC. SC 13D 32421
  Complete submission text file 0000950112-96-001127.txt   34697
Mailing Address ONE EMBARCADERO CENTER STE 2300 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 2300 SAN FRANCISCO CA 94111 4153620292
AMERINDO INVESTMENT ADVISORS INC (Filed by) CIK: 0000860655 (see all company filings)

IRS No.: 942997472 | State of Incorp.: CA | Fiscal Year End: 0430

Mailing Address 3550 GENERAL ATOMICS COURT SANSAN DIEGO CA 92121
Business Address 3550 GENERAL ATOMICS COURT SAN DIEGO CA 92121 6194553814
HOUGHTEN PHARMACEUTICALS INC (Subject) CIK: 0000887920 (see all company filings)

IRS No.: 510336233 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45713 | Film No.: 96546852
SIC: 2836 Biological Products, (No Diagnostic Substances)